Premixed Insulins (70/30, 50/50) Injectable Suppliers & Bulk Manufacturers

Available Forms: Vials, pens

Available Strengths: U-100

Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)

Category: Diabetes

Premixed insulins (70/30, 50/50) combine rapid-acting and intermediate-acting insulins, providing both prandial and basal blood sugar control. They offer convenience with fewer injections, improve glycemic stability, and simplify management for type 2 diabetes patients. Their predictable action helps reduce post-meal spikes and fasting hyperglycemia. Premixed Insulins (70/30, 50/50) Injectable is available in Vials, pens and strengths such as U-100. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Premixed Insulins (70/30, 50/50) Injectable is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Premixed Insulins (70/30, 50/50) Injectable can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Premixed insulins (70/30, 50/50) are regulated in the EU and US as combination biological medicines. In the EU, brands like Mixtard and Humulin 70/30 are approved by EMA based on comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, the FDA has approved products like Humulin 70/30 and Novolin 70/30, supported by detailed clinical data and biosimilarity assessments, with ongoing pharmacovigilance. Both regions require robust regulatory dossiers for approval and post-marketing safety. For expert support with pharmaceutical dossiers and compliance, visit PharmaTradz, your trusted partner in regulatory solutions.